HCA Healthcare Inc. reported first-quarter 2026 financial results showing revenue of $19.109 billion, representing a 4.3% year-over-year increase. Net income rose slightly to $1.620 billion, while diluted earnings per share grew by 10.9% to $7.15. Adjusted EBITDA reached $3.802 billion, up 1.9%, and cash flows from operating activities increased significantly by 22% to $2.014 billion. Operational performance included a 0.9% increase in same-facility admissions and a 1.3% rise in equivalent admissions, though the company noted an absence of typical seasonal volume growth due to a 42% decline in respiratory-related admissions and severe winter storms in January. Same-facility inpatient and outpatient surgeries also saw slight declines compared to Q1 2025. CEO Sam Hazen credited staff adaptation to these conditions, while unfavorable impacts on patient volumes were largely mitigated by the recognition of specific Medicaid supplemental programs not accounted for in initial 2026 financial guidance. HCA Healthcare operates as a leading American for-profit company providing healthcare services through 186 hospitals and approximately 2,400 sites of care across 20 states and the UK. The article includes promotional content about AI stocks and subscription offers, but the core reporting on HCA's financial performance and operational metrics remains substantive.